<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Pharmaceutical Technology articles</title><description>Pharmaceutical Technology articles</description><link>https://www.pharmtech.com/news</link><category>Pharmaceutical Technology articles</category><copyright>© 2026 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.</copyright><lastBuildDate>Mon, 16 Nov 2026 18:31:47 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.pharmtech.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Pharmaceutical Technology articles</title><width>144</width><height>47</height><link>https://www.pharmtech.com/news</link><url>https://www.pharmtech.com/logo.webp</url></image><item><title>&lt;![CDATA[New Proposals and Legislation Strengthen Europe’s Position in the Pharmaceutical Arena]]&gt;</title><link>https://www.pharmtech.com/view/new-proposals-and-legislation-strengthen-europe-s-position-in-the-pharmaceutical-arena</link><guid isPermaLink="true">https://www.pharmtech.com/view/new-proposals-and-legislation-strengthen-europe-s-position-in-the-pharmaceutical-arena</guid><description>&lt;![CDATA[Proposal for the Public Procurement Act, adoption of a new pharmaceutical legislation, and revision of pharmacovigilance practices should improve patient access to safe and innovative medicines in Europe.]]&gt;</description><pubDate>Mon, 16 Nov 2026 13:43:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[PharmTech’s Weekly Roundup—November 13, 2026: AI Accountability, Anticounterfeiting, and FDA Approvals]]&gt;</title><link>https://www.pharmtech.com/view/pharmtech-s-weekly-roundup-november-13-2026-ai-accountability-anticounterfeiting-and-fda-approvals</link><guid isPermaLink="true">https://www.pharmtech.com/view/pharmtech-s-weekly-roundup-november-13-2026-ai-accountability-anticounterfeiting-and-fda-approvals</guid><description>&lt;![CDATA[This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.]]&gt;</description><pubDate>Fri, 13 Nov 2026 18:37:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Manufacturing Intelligence: AI Poisoning Demands Pharma Data Stewards]]&gt;</title><link>https://www.pharmtech.com/view/manufacturing-intelligence-ai-poisoning-demands-pharma-data-stewards</link><guid isPermaLink="true">https://www.pharmtech.com/view/manufacturing-intelligence-ai-poisoning-demands-pharma-data-stewards</guid><description>&lt;![CDATA[Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.]]&gt;</description><pubDate>Fri, 13 Nov 2026 17:45:54 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Beyond Gloveless: Managing Intervention Dependency in Robotic Aseptic Filling]]&gt;</title><link>https://www.pharmtech.com/view/beyond-gloveless-managing-intervention-dependency-robotic-aseptic-filling</link><guid isPermaLink="true">https://www.pharmtech.com/view/beyond-gloveless-managing-intervention-dependency-robotic-aseptic-filling</guid><description>&lt;![CDATA[Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.]]&gt;</description><pubDate>Thu, 12 Nov 2026 18:05:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Investing in Protecting Pharma Products ]]&gt;</title><link>https://www.pharmtech.com/view/investing-in-protecting-pharma-products</link><guid isPermaLink="true">https://www.pharmtech.com/view/investing-in-protecting-pharma-products</guid><description>&lt;![CDATA[Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.

]]&gt;</description><pubDate>Thu, 12 Nov 2026 17:54:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews]]&gt;</title><link>https://www.pharmtech.com/view/fda-shelves-priority-voucher-pilot-stalling-fast-track-drug-reviews</link><guid isPermaLink="true">https://www.pharmtech.com/view/fda-shelves-priority-voucher-pilot-stalling-fast-track-drug-reviews</guid><description>&lt;![CDATA[The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.]]&gt;</description><pubDate>Thu, 12 Nov 2026 15:40:58 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[AI Pulse Check: Owned AI Models Ease Validation]]&gt;</title><link>https://www.pharmtech.com/view/ai-pulse-check-owned-ai-models-ease-validation</link><guid isPermaLink="true">https://www.pharmtech.com/view/ai-pulse-check-owned-ai-models-ease-validation</guid><description>&lt;![CDATA[Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.]]&gt;</description><pubDate>Thu, 12 Nov 2026 12:30:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Choosing a Connected Product Technology for Anticounterfeiting]]&gt;</title><link>https://www.pharmtech.com/view/choosing-a-connected-product-technology-for-anticounterfeiting</link><guid isPermaLink="true">https://www.pharmtech.com/view/choosing-a-connected-product-technology-for-anticounterfeiting</guid><description>&lt;![CDATA[Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.]]&gt;</description><pubDate>Wed, 11 Nov 2026 21:21:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Green Chemistry Supply and Demand in Sustainable Pharma]]&gt;</title><link>https://www.pharmtech.com/view/green-chemistry-supply-and-demand-in-sustainable-pharma</link><guid isPermaLink="true">https://www.pharmtech.com/view/green-chemistry-supply-and-demand-in-sustainable-pharma</guid><description>&lt;![CDATA[Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.]]&gt;</description><pubDate>Wed, 11 Nov 2026 20:35:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Leveraging Orthogonal Analytical Techniques for Complex Therapeutic Modalities]]&gt;</title><link>https://www.pharmtech.com/view/leveraging-orthogonal-analytical-techniques-for-complex-therapeutic-modalities</link><guid isPermaLink="true">https://www.pharmtech.com/view/leveraging-orthogonal-analytical-techniques-for-complex-therapeutic-modalities</guid><description>&lt;![CDATA[Matt Whelihan, associate director of research and development at Prolytix, discusses industry trends—from data-driven approaches built on artificial intelligence (AI) to increasingly complex therapeutic modalities.]]&gt;</description><pubDate>Wed, 11 Nov 2026 17:39:26 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[CPHI Pharma Award Winner: Drug Delivery, Devices, &amp; Packaging]]&gt;</title><link>https://www.pharmtech.com/view/cphi-pharma-award-winner-drug-delivery-devices-packaging</link><guid isPermaLink="true">https://www.pharmtech.com/view/cphi-pharma-award-winner-drug-delivery-devices-packaging</guid><description>&lt;![CDATA[Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting. ]]&gt;</description><pubDate>Wed, 11 Nov 2026 15:59:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Pimicotinib TGCT Approval Shows How Assessment Aid Supports Review]]&gt;</title><link>https://www.pharmtech.com/view/pimicotinib-tgct-approval-shows-how-assessment-aid-supports-review</link><guid isPermaLink="true">https://www.pharmtech.com/view/pimicotinib-tgct-approval-shows-how-assessment-aid-supports-review</guid><description>&lt;![CDATA[FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.]]&gt;</description><pubDate>Wed, 11 Nov 2026 15:37:34 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Mike Riley on Veranova’s Vision and Strategy]]&gt;</title><link>https://www.pharmtech.com/view/mike-riley-on-veranova-s-vision-and-strategy</link><guid isPermaLink="true">https://www.pharmtech.com/view/mike-riley-on-veranova-s-vision-and-strategy</guid><description>&lt;![CDATA[Mike Riley, CEO of Veranova, discusses how people-first leadership, deep experience in complex chemistries, and close collaboration with customers position the CDMO to support increasingly complex modalities. ]]&gt;</description><pubDate>Wed, 11 Nov 2026 14:57:53 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[CPHI Award for Sustainable Pharma Excellence: Green Chemicals]]&gt;</title><link>https://www.pharmtech.com/view/cphi-award-for-sustainable-pharma-excellence-green-chemicals</link><guid isPermaLink="true">https://www.pharmtech.com/view/cphi-award-for-sustainable-pharma-excellence-green-chemicals</guid><description>&lt;![CDATA[Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing. ]]&gt;</description><pubDate>Wed, 11 Nov 2026 13:20:38 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Top Use Cases and Applications for PROCIPIENT® Sterile]]&gt;</title><link>https://www.pharmtech.com/view/top-use-cases-and-applications-for-procipient-sterile</link><guid isPermaLink="true">https://www.pharmtech.com/view/top-use-cases-and-applications-for-procipient-sterile</guid><description>&lt;![CDATA[Sandra Reid, senior director of sales at gChem, shares what scientists should be asking before choosing a sterile DMSO for their next cell therapy or parenteral program.]]&gt;</description><pubDate>Tue, 10 Nov 2026 18:12:13 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Our Biggest Takeaways From AAPS PharmSci 360]]&gt;</title><link>https://www.pharmtech.com/view/our-biggest-takeaways-from-aaps-pharmsci-360</link><guid isPermaLink="true">https://www.pharmtech.com/view/our-biggest-takeaways-from-aaps-pharmsci-360</guid><description>&lt;![CDATA[From AI validation to microstructure imaging, AAPS PharmSci 360 speakers pushed toward faster drug development backed by stronger evidence. Here are PharmTech&apos;s biggest takeaways.]]&gt;</description><pubDate>Tue, 10 Nov 2026 17:57:41 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[What the First Factor XIa Approval Means for Developers]]&gt;</title><link>https://www.pharmtech.com/view/what-the-first-factor-xia-approval-means-for-developers</link><guid isPermaLink="true">https://www.pharmtech.com/view/what-the-first-factor-xia-approval-means-for-developers</guid><description>&lt;![CDATA[The FDA approves asundexian, the first factor XIa inhibitor, cutting stroke risk 26% and setting a regulatory benchmark for factor XI drug developers.]]&gt;</description><pubDate>Tue, 10 Nov 2026 15:25:53 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[PharmTech AI Pulse Check: Who&apos;s Accountable When a Vendor&apos;s AI Model Changes?]]&gt;</title><link>https://www.pharmtech.com/view/pharmtech-ai-pulse-check-whos-accountable-when-a-vendors-ai-model-changes</link><guid isPermaLink="true">https://www.pharmtech.com/view/pharmtech-ai-pulse-check-whos-accountable-when-a-vendors-ai-model-changes</guid><description>&lt;![CDATA[Panelists on the PharmTech AI Pulse Check weigh a December AI playbook, EMA/MHRA moves, PCCP accountability gaps, and MCP-ready regulatory guidance.]]&gt;</description><pubDate>Tue, 10 Nov 2026 14:16:18 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[France Remains One of Europe’s Leading Biotech Funding Hubs]]&gt;</title><link>https://www.pharmtech.com/view/france-remains-one-of-europe-s-leading-biotech-funding-hubs</link><guid isPermaLink="true">https://www.pharmtech.com/view/france-remains-one-of-europe-s-leading-biotech-funding-hubs</guid><description>&lt;![CDATA[France’s 2030 Health Initiative is driving growth in biotechnology, health innovation, biomanufacturing, and digital health. ]]&gt;</description><pubDate>Tue, 10 Nov 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites]]&gt;</title><link>https://www.pharmtech.com/view/the-impact-of-excipients-on-continuous-manufacturing-and-the-risk-of-nitrites</link><guid isPermaLink="true">https://www.pharmtech.com/view/the-impact-of-excipients-on-continuous-manufacturing-and-the-risk-of-nitrites</guid><description>&lt;![CDATA[CPHI Award winner, Pauline van der Wijst-Janssen, PhD, product development manager and global technical lead at DFE Pharma, explains excipient variability and excipients’ role in continuous manufacturing. ]]&gt;</description><pubDate>Mon, 09 Nov 2026 20:55:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen]]&gt;</title><link>https://www.pharmtech.com/view/cphi-milan-future-leader-award-winner-pauline-van-der-wijst-janssen</link><guid isPermaLink="true">https://www.pharmtech.com/view/cphi-milan-future-leader-award-winner-pauline-van-der-wijst-janssen</guid><description>&lt;![CDATA[Pauline van der Wijst-Janssen, PhD, of DFE Pharma, won the CPHI Pharma Award for Future Leader. In this interview with PharmTech, she provides advice for scientists looking to advance to leadership roles.]]&gt;</description><pubDate>Mon, 09 Nov 2026 19:03:41 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[PharmTech’s Weekly Roundup—November 6, 2026: Impurities, Supply Resilience, and AI Accountability]]&gt;</title><link>https://www.pharmtech.com/view/pharmtech-s-weekly-roundup-november-6-2026-impurities-supply-resilience-and-ai-accountability</link><guid isPermaLink="true">https://www.pharmtech.com/view/pharmtech-s-weekly-roundup-november-6-2026-impurities-supply-resilience-and-ai-accountability</guid><description>&lt;![CDATA[Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.]]&gt;</description><pubDate>Mon, 09 Nov 2026 18:30:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Drapeau’s AI Deep Dive: Qualify the Reviewer Before the AI Goes Live]]&gt;</title><link>https://www.pharmtech.com/view/drapeaus-ai-deep-dive-qualify-the-reviewer-before-the-ai-goes-live</link><guid isPermaLink="true">https://www.pharmtech.com/view/drapeaus-ai-deep-dive-qualify-the-reviewer-before-the-ai-goes-live</guid><description>&lt;![CDATA[No operator touches a CAR-T batch before demonstrating proficiency. Generative AI users should meet the same standard, and a higher one, because an AI error does not stay inside one batch.]]&gt;</description><pubDate>Mon, 09 Nov 2026 17:10:43 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[$1.15B AI-Guided Macrocycle Discovery Lands at argenx]]&gt;</title><link>https://www.pharmtech.com/view/ai-guided-macrocycle-discovery-lands-at-argenx-in-1-15b-deal</link><guid isPermaLink="true">https://www.pharmtech.com/view/ai-guided-macrocycle-discovery-lands-at-argenx-in-1-15b-deal</guid><description>&lt;![CDATA[argenx will acquire Unnatural Products for up to $1.15B, bringing oral macrocyclic peptides and new formulation challenges to its antibody portfolio.]]&gt;</description><pubDate>Mon, 09 Nov 2026 15:23:36 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing]]&gt;</title><link>https://www.pharmtech.com/view/cdmos-oems-and-used-equipment-resellers-are-joining-forces-to-onshore-pharmaceutical-manufacturing</link><guid isPermaLink="true">https://www.pharmtech.com/view/cdmos-oems-and-used-equipment-resellers-are-joining-forces-to-onshore-pharmaceutical-manufacturing</guid><description>&lt;![CDATA[Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.]]&gt;</description><pubDate>Fri, 06 Nov 2026 19:56:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Supply Chain Excellence: Managing Temperature and Time Requirements for Ultra-Rare Therapies]]&gt;</title><link>https://www.pharmtech.com/view/supply-chain-excellence-managing-temperature-and-time-requirements-for-ultra-rare-therapies</link><guid isPermaLink="true">https://www.pharmtech.com/view/supply-chain-excellence-managing-temperature-and-time-requirements-for-ultra-rare-therapies</guid><description>&lt;![CDATA[Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains how her team managed the study’s strict −80 °C handling requirement, quality release, and site readiness, and how the Almac Adapt approach can apply beyond this program.]]&gt;</description><pubDate>Fri, 06 Nov 2026 19:46:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[PharmTech AI Pulse Check: Why Pharma&apos;s AI Compliance Doesn&apos;t End at Go-Live]]&gt;</title><link>https://www.pharmtech.com/view/pharmtech-ai-pulse-check-why-pharmas-ai-compliance-doesnt-end-at-go-live</link><guid isPermaLink="true">https://www.pharmtech.com/view/pharmtech-ai-pulse-check-why-pharmas-ai-compliance-doesnt-end-at-go-live</guid><description>&lt;![CDATA[The PharmTech AI Pulse Check panel discusses why MHRA and FDA oversight of pharma AI continues past go-live, and who validates the regulators&apos; own AI.]]&gt;</description><pubDate>Fri, 06 Nov 2026 18:05:09 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Meeting Tomorrow&apos;s Market Requirements: Vetter&apos;s Perspective on the Future of Fill &amp; Finish]]&gt;</title><link>https://www.pharmtech.com/view/meeting-tomorrow-s-market-requirements-vetter-s-perspective-on-the-future-of-fill-finish</link><guid isPermaLink="true">https://www.pharmtech.com/view/meeting-tomorrow-s-market-requirements-vetter-s-perspective-on-the-future-of-fill-finish</guid><description>&lt;![CDATA[Christine Fuerst and Gregor Deutschle of Vetter Pharma International GmbH discuss what pharmaceutical and biotech companies expect from a fill and finish CDMO partner today.]]&gt;</description><pubDate>Fri, 06 Nov 2026 15:48:37 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Why Amivantamab&apos;s Approval Matters to Formulators]]&gt;</title><link>https://www.pharmtech.com/view/why-amivantamab-approval-matters-to-formulators</link><guid isPermaLink="true">https://www.pharmtech.com/view/why-amivantamab-approval-matters-to-formulators</guid><description>&lt;![CDATA[The FDA grants accelerated approval to subcutaneous amivantamab for head and neck cancer, extending the IV-to-subcutaneous shift in biologics formulation.]]&gt;</description><pubDate>Fri, 06 Nov 2026 15:20:35 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item><item><title>&lt;![CDATA[Why Drug Shortages Average 5+ Years: PharmTech Explained]]&gt;</title><link>https://www.pharmtech.com/view/why-drug-shortages-average-5-years-pharmtech-explained</link><guid isPermaLink="true">https://www.pharmtech.com/view/why-drug-shortages-average-5-years-pharmtech-explained</guid><description>&lt;![CDATA[USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.]]&gt;</description><pubDate>Fri, 06 Nov 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Technology</media:credit><category>us</category><source url="https://www.pharmtech.com/rss.xml">Pharmaceutical Technology Articles</source></item></channel></rss>